112736-11-5 Usage
Uses
Used in Pharmaceutical Industry:
6-Methylpicolinamidamide hydrochloride is used as a reagent in the preparation of various pharmaceuticals. Its unique structure and properties contribute to the development of new and effective drugs, enhancing their therapeutic potential and efficacy.
Used in Agrochemical Industry:
6-Methylpicolinamidamide hydrochloride is also used as a reagent in the preparation of agrochemicals. Its diverse reactivity allows for the creation of new compounds that can improve crop protection and increase agricultural productivity.
Used in Medicinal Chemistry:
6-Methylpicolinamidamide hydrochloride is employed as a valuable tool in medicinal chemistry due to its compatibility with a range of functional groups. This enables the development of novel compounds with potential therapeutic applications, contributing to advancements in drug discovery and design.
Used in Material Science:
6-Methylpicolinamidamide hydrochloride has potential applications in material science, where its unique properties can be utilized to create new materials with specific characteristics. This can lead to the development of innovative products and technologies in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 112736-11-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,7,3 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 112736-11:
(8*1)+(7*1)+(6*2)+(5*7)+(4*3)+(3*6)+(2*1)+(1*1)=95
95 % 10 = 5
So 112736-11-5 is a valid CAS Registry Number.
112736-11-5Relevant academic research and scientific papers
SUBSTITUTED PYRIMIDINES AND METHODS OF USE
-
, (2021/10/11)
The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.
Growth Factor Receptor antagonists. Preparation method and application thereof
-
, (2021/11/10)
The invention relates to a small molecule antagonist for transforming growth factor β receptors, a method for preparing the small molecule antagonist, and application of the small molecule antagonist in preparation of drugs. The small molecule antagonist for transforming the growth factor β receptor has the application of treating and/or preventing various diseases mediated by ALK5, and has great clinical application potential.
HETEROCYCLIC COMPOUND
-
Paragraph 0546; 0574, (2016/09/26)
The problem of the present invention is to provide a compound having a PDE2A inhibitory action, and useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
NEW COMPOUNDS
-
Page/Page column 11, (2010/02/13)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
